[Current views on the pathogenesis of hematuria of unknown etiology].
D000614:Aminocaproates / Q000627:therapeutic use; D007611:Aprotinin / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000150:complications; D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006417:Hematuria / Q000209:etiology*; D006474:Hemorrhagic Disorders / Q000150:complications; D006801:Humans; D014118:Toxins, Biological; D014552:Urinary Tract Infections / Q000150:complications; D014556:Urine / Q000032:analysis
D000614:Aminocaproates; D005343:Fibrinolytic Agents; D014118:Toxins, Biological; D007611:Aprotinin
Neuere Gesichtspunkte zur Pathogenese der ätiologisch ungeklärten Hämaturie.